Will Maier

@WillMaier1

Better Health Care For All Patients! Chief Scientific Officer/Head, Rare Disease Commercialisation and Outcomes

London, UK
Vrijeme pridruživanja: lipanj 2011.

Tweetovi

Blokirali ste korisnika/cu @WillMaier1

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @WillMaier1

  1. 20. pro 2019.
    Poništi
  2. 10. pro 2019.
    Poništi
  3. 4. pro 2019.

    ICON is delighted to accept best CRO of the year at the 15th annual tonight in London

    Poništi
  4. 8. stu 2019.
    Poništi
  5. proslijedio/la je Tweet
    10. srp 2019.

    I will chair and speak at a session on Orphan Drugs on 27th July at this conference in Kyoto Japan. See you there.

    Poništi
  6. 10. srp 2019.

    I will chair and speak at a session on Orphan Drugs on 27th July at this conference in Kyoto Japan. See you there.

    Poništi
  7. 7. velj 2018.
    Poništi
  8. 6. velj 2018.
    Poništi
  9. 20. lis 2017.
    Poništi
  10. 20. lis 2017.
    Poništi
  11. proslijedio/la je Tweet

    ICON has acquired Mapi Group, extending the breadth and depth of our late phase capabilities:

    Poništi
  12. 20. lip 2017.
    Poništi
  13. 20. lip 2017.
    Poništi
  14. 20. lip 2017.
    Odgovor korisnicima

    Talk by Valerie Powell of Mapi

    Poništi
  15. 20. lip 2017.
    Poništi
  16. 20. lip 2017.
    Poništi
  17. 13. lip 2017.
    Poništi
  18. proslijedio/la je Tweet
    7. lip 2017.

    Mapi's new Patient Centered Sciences group that I head up. See you Chicago 19 to 22 June.

    Poništi
  19. 7. lip 2017.

    Mapi's new Patient Centered Sciences group that I head up. See you Chicago 19 to 22 June.

    Poništi
  20. 20. ruj 2016.
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·